These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
783 related articles for article (PubMed ID: 9840942)
1. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839 [TBL] [Abstract][Full Text] [Related]
3. Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms. Silva J; Silva JM; Domínguez G; García JM; Cantos B; Rodríguez R; Larrondo FJ; Provencio M; España P; Bonilla F J Pathol; 2003 Mar; 199(3):289-97. PubMed ID: 12579530 [TBL] [Abstract][Full Text] [Related]
4. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer. Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146 [TBL] [Abstract][Full Text] [Related]
5. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214 [TBL] [Abstract][Full Text] [Related]
6. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas. Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133 [TBL] [Abstract][Full Text] [Related]
7. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC). Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931 [TBL] [Abstract][Full Text] [Related]
8. INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis. Hui R; Macmillan RD; Kenny FS; Musgrove EA; Blamey RW; Nicholson RI; Robertson JF; Sutherland RL Clin Cancer Res; 2000 Jul; 6(7):2777-87. PubMed ID: 10914724 [TBL] [Abstract][Full Text] [Related]
9. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420 [TBL] [Abstract][Full Text] [Related]
10. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland. Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265 [TBL] [Abstract][Full Text] [Related]
11. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170 [TBL] [Abstract][Full Text] [Related]
12. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835 [TBL] [Abstract][Full Text] [Related]
13. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414 [TBL] [Abstract][Full Text] [Related]
14. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Kim DH; Nelson HH; Wiencke JK; Zheng S; Christiani DC; Wain JC; Mark EJ; Kelsey KT Cancer Res; 2001 Apr; 61(8):3419-24. PubMed ID: 11309302 [TBL] [Abstract][Full Text] [Related]
15. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands. Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172 [TBL] [Abstract][Full Text] [Related]
16. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status. Chaussade L; Eymin B; Brambilla E; Gazzeri S Oncogene; 2001 Oct; 20(45):6587-96. PubMed ID: 11641784 [TBL] [Abstract][Full Text] [Related]
17. The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16INK4a/MTS1 gene. Della Valle V; Duro D; Bernard O; Larsen CJ Oncogene; 1997 Nov; 15(20):2475-81. PubMed ID: 9395243 [TBL] [Abstract][Full Text] [Related]
18. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance. Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757 [TBL] [Abstract][Full Text] [Related]
19. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Herzog CR; Soloff EV; McDoniels AL; Tyson FL; Malkinson AM; Haugen-Strano A; Wiseman RW; Anderson MW; You M Oncogene; 1996 Nov; 13(9):1885-91. PubMed ID: 8934534 [TBL] [Abstract][Full Text] [Related]
20. [Relationship between alterations of p16INK4a and p14ARF genes of CDKN2A locus and gastric carcinogenesis]. Tang SH; Yang DH; Luo HS; Yu JP; Shu JC Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):517-21. PubMed ID: 15231134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]